- RecruitingPHASE3
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
This study compares two new treatments, brelovitug and bulevirtide, for chronic Hepatitis Delta. It aims to see which is more effective for people with this liver condition, helping us find better long-term solutions.
For: Chronic Hepatitis D InfectionAustria · Czechia · France - Active not recruitingPHASE2, PHASE3
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection
This study is looking at a new medicine called Brelovitug (BJT-778) for chronic Hepatitis Delta. It compares different doses of the medicine and also looks at starting treatment now versus starting it later to see how well it works and if it's safe.
For: Chronic Hepatitis D InfectionUnited States · Australia · Bulgaria